CTIF and Parkinson disease: Using double immunofluorescence and confocal microscopic analysis, we found that CTIF-immunoreactive structures in PD patients co-localized with α-synuclein-immunoreactive bodies, which were not detected in sections from the normal brain (Fig. 7b).